X0609 4 2026-07-09 0001099800 Edwards Lifesciences Corp EW 0002013495 Mistras Theodora false ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Chief Financial Officer 0 Common Stock 2026-07-09 4 A 0 87595.0000 0.0000 A 87595.0000 D Common Stock 2026-07-09 4 A 0 12325.0000 0.0000 A 99920.0000 D Employee Stock Option (Right to Acquire) 91.3300 2026-07-09 4 A 0 61800.0000 0.0000 A 2027-07-09 2033-07-08 Common Stock 61800.0000 61800.0000 D Performance Rights 2026-07-09 4 A 0 12325.0000 0.0000 A 2029-07-09 Common Stock 12325.0000 12325.0000 D These restricted stock units were granted on July 9, 2026, under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest as follows: 43.75% on the first anniversary of May 29, 2026 (the "Start Date"), 50% on the second anniversary of the Start Date, and the remaining 6.25% on the third anniversary of the Start Date. These restricted stock units were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. These options were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2026-07-10